Uncategorized

MidEuropa announces today that it has signed an agreement to acquire a controlling stake in FAMAR, a well-established pharmaceutical contract development and manufacturing organisation (CDMO), from ECM Partners and Metric Capital Partners. MidEuropa will invest alongside the management team and current shareholders, who will retain a minority stake. The transaction, which is subject to customary…

We are delighted to announce that Robert Knorr, Managing Partner at MidEuropa, has been recognised as the Mid-Cap Private Equity Investment Leader for 2024 at the Real Deals Private Equity Awards, the longest running and most prestigious such awards in Europe. The decision was made by an expert judging panel, which included a number of…

MidEuropa has received validation of our emissions reduction targets by the Science Based Target initiative (SBTi). These targets are consistent with the levels required to meet the Paris Agreement goals and limit warming to 1.5°C. Our targets: Commit to reduce absolute scope 1 and 2 GHG emissions 42% by 2030 from a 2021 base year.…

MidEuropa, a leading European private equity investor with deep roots in Central Europe, today announces that it has entered into an agreement to sell Profi Rom Food (“Profi or the “Company”), one of Romania’s major food retailers, to Ahold Delhaize for an Enterprise Value of approximately EUR1.3 billion pre-IFRS16 (EUR1.8 billion post-IFRS 16). Profi is…

MidEuropa, the leading private equity investor in Central Europe, announced today that it has completed the sale of a majority stake in Symfonia to Accel-KKR, a leading global technology investment firm focused on software and tech-enabled companies. MidEuropa will retain a significant minority stake in the business. MidEuropa acquired Symfonia in March 2021 in a…

MidEuropa, a leading investor in Central Europe, is pleased to announce the sale of a majority stake in Symfonia to Accel-KKR, a leading global technology investment firm focused on software and tech-enabled companies. Upon completion of the transaction, MidEuropa will retain a significant minority stake in the business, reflecting the firm’s strong conviction in Symfonia’s…

MidEuropa, the leading private equity investor in Central Europe, announced today that it has completed the acquisition of a majority stake in Optegra Eye Health Care (“Optegra” or the “Company”) from H2 Equity Partners, which is reinvesting alongside MidEuropa and the Company’s management team. Optegra is a leading European ophthalmology platform operating in Poland, Czech…